End-stage Liver Disease (ESLD) research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE1, PHASE2
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
This study looks into a new treatment called RTX001 for severe liver disease like cirrhosis. It's made from your own cells and aims to reduce inflammation and scarring in the liver. This is the first time it will be tested in people to see if it's safe and effective.
Spain · United Kingdom - recruiting
LEOPARD Training and Validation Data Collection Study
This study aims to improve how we predict who needs a new liver transplant most urgently. Researchers are collecting health information from patients with severe liver diseases across Europe to create better tools, using artificial intelligence, to help decide who gets a liver transplant and when.
Austria · Belgium · France - recruiting
TIPS in Patients With Decompensated Liver Cirrhosis
This study looks at how a treatment called TIPS helps people with serious liver disease at Hannover Medical School. Researchers are collecting information and blood samples to make this treatment even better for those who need it.
Germany